黑料网

ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Infect Dis Ther, Vol 8(5)
  • DOI: 10.4172/2332-0877.1000435

The Effect of Post Chlamydia Trachomatis Infection Treatment on Reactive Oxygen Species and Sperm Parameters of Infertile Men

Reza Azmakan1*, Reza Salman Yazdi1, Faramarz Farahi1, Vahid Esmaeili1, Seyed Kazem Bidoki2 and Saied Jafari3
1Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
2Department of Biology, Payame Noor University, Tehran, Iran
3Department of Veterinary Public Health, Chulalongkorn University, Bangkok, Thailand
*Corresponding Author: Reza Azmakan, Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran, Email: rezaazmakan@yahoo.com

Received: 12-Oct-2020 / Accepted Date: 26-Oct-2020 / Published Date: 02-Nov-2020 DOI: 10.4172/2332-0877.1000435

Abstract

Chlamydia Trachomatis (CT) infection is often mentioned as a silent disease. Reactive Oxygen Species (ROS) can also cause Sperm apoptosis and have negative impact on Sperm parameters. The objectives of this study were to elucidate the association between Sperm parameters and ROS caused by CT infections resulting in male Infertility as well as evaluating the role of antibiotic therapy. A total of 848 infertile males having normal and abnormal Sperm parameters were included. After Semen sampling, the CT IgA were measured by Elisa and confirmed by Nested PCR. ROS was determined by Chemiluminescence. After treatment under the direct supervision of the private urologists. Then, the second Semen samples were taken and subjected to tests on Sperm parameters and ROS levels as assessed again. The levels of ROS and morphology were improved following the treatments (P<0.05). Antibiotic therapy due to CT infection, could reduce ROS, improve normal morphology and recover some of Semen parameters. Our findings indicate that CT infection and Sperm parameters were associated with the rate of ROS in infertile men. However, after treatment, ROS value dropped allowing the recovery of certain Sperm parameters.

Antibiotic therapy can improve some Semen quality parameters and treat the male Infertility.

Keywords: Antibiotic treatment; Chlamydia trachomatis; Male infertility; Reactive oxygen species; Sperm parameters

Introduction

It has been reported that about 10 to 15% of couples suffer from Infertility due to different incentives. Bacterial infections of the reproductive system are one of the causes of Infertility (8 to 35%) [1]. Infection could lead to deterioration of Spermatogenesis, impairment of Sperm function and/or obstruction of the seminal tract. The major pathogens are Chlamydia trachomatis, Neisseria gonorrhoeae, and some genital Mycoplasma [2]. Chlamydia trachomatis causes at least 50% of common bacterial Sexually transmitted infections in the world [3]. Infection of Semen and male sex gland with CT is associated with was increased ROS levels, was increased motility and Sperm morphology which are important factors in men Infertility. Chlamydia trachomatis is known as a silent disease. Reactive Oxygen Species (ROS) including oxygen ions, free radicals and peroxide is produced by Sperm and leukocytes in the Semen [4]. ROS has a dual role in male fertility. On one hand carrying capacity, acrosome reaction and fertilizing, and on the other hand causing severe damages to the Sperm. Effects of Infertility caused by ROS are; Sperm membrane damage, reduced Sperm mobility and inability to fuse with the oocyte cell. ROS can also alter Sperm DNA, pass through the damaged DNA paternity and reach embryo. Was increased ROS can result in disruption of the structure and increase permeability that the lack of fertilization and abnormally shaped cells will follow [5]. Chlamydial IgA antibodies in seminal fluid can activate the immune system and the ROS leads to was increased lipid peroxidation of Sperm membrane and Spermatozoa apoptotic effects [6]. Reduced Sperm motility is caused by H2O2 penetration into the cell and inhibits the activity of some enzymes, which leads to was decreased phosphorylation of axonemal protein and was decreased Sperm motility [7].

Sensitivity and specificity of molecular methods, especially Nucleic Acid Amplification Test (NAAT) is high for the diagnosis of chlamydial infection in Semen inside urine [8]. Diagnosis of chlamydial infection and methods for measuring ROS are done in a variety of ways. Methods of measuring ROS such as; Direct method-measurement of MDA by thiobarbituric LPO [9], Measuring isoprostanes [10], Urinary 8 OHDG [11], Sperm Chromatin Dispersion Test (SCD) [12], COMET method, TUNEL as well as indirect methods; Chemiluminescence methodsmeasuring superoxide ions produced by lucigenin sensitive probes which is an indicator to quantify the oxidation activity.

The aims of this study were to compare the frequency of genital C.trachomatis (with normal and abnormal Semen parameters), to elucidate the association of asymptomatic infections with male Infertility, to evaluate the effect of antibiotic treatment on improvement of Spermatozoa parameters, and to examine ROS levels and Sperm parameters before and after treatment in infected infertile men.

Methodology

Study population

The primary sample size was 848 Semen samples. Samples were taken from men with normal and abnormal Semen (low Sperm count, leukocytoSpermia, low Sperm progressive motility, low normal morphology). Of the 848 input samples, 10 samples tested by Elisa positive C. trachomatis were reported. Eight positive samples (by nested PCR) were certain that one sample was excluded due to non-recourse and 7 samples were analyzed. Sperm parameter and ROS level were compared before and after treatment with antibiotics (7 patients). The average age of peoples in this study was 31.8 ± 0.5 years (ranging from 21 to 57). The mean duration of Infertility for study group was 58.2 ± 2.9 month.

Results

Frequency of C. trachomatis between the study groups

Of 848 patients (with normal and abnormal Sperm) included in the study group (infertile men), seven (0.83%) were tested positive for C. trachomatis. All infected patients in the study group were resolved from the infection after the treatment completion.

Semen parameters

Of 848 patients (with normal and abnormal Sperm) included in the study group (infertile men), seven (0.83%) were tested positive for C. trachomatis. All infected patients in the study group were resolved from the infection after the treatment completion.

Frequency of C. trachomatis between the study groups

Tables 1 and 2 compares the Semen parameters before and after the antibiotic therapy, respectively. Figure 1 shows the Semen parameters in infected infertile men before and after the antibiotic therapy. There was not statistically significant difference in the Semen parameters. The count of leukocytes, Sperm count, total motility, Class A (rapid progressive), class D (non-motile), volume of Semen and pH Semen after treatment, the parameters of recovery showed improvement with no significant differences (P>0.05.). Motility of the Class B (progressive) and class C (non-progressive) had no significant differences. The mean count of white blood cells in the pre-treatment sample was 0.41 ± 0.518 million per ml, and the mean count of white blood cells in the samples after treatment was 0.09 ± 0.146 million per ml, The count of WBC was decreased after treatment compared with before treatment, but this reduction was not significant (P-value=0.144). The Sperm count was increased numerically after treatment, but this increase was not significantly different (P-value=0.128). The Sperm motility was increased numerically after treatment compared with before treatment, but this increase was not significantly different (P-value=0.398). Sperm motility including class A, class B, class C and class D before and after treatment was not significant (P-value=0.138). The volume of Sperm samples was not statistically significant before and after treatment (P-value=0.249). The pH Semen samples were not statistically significant before and after treatment (P-value=0.157). The normal morphology after treatment compared with the baseline was significantly was increased (P-value=0.024).

Semen parameters Z-value P-value
After ROS total/Before ROS total 2.023a 0.043*
After ROS WBC/Before ROS WBC 2.023a 0.043*
After ROS base/Before ROS base 2.023a 0.043*
After pH/Before pH 1.414a 0.157ns
After normal morphology 2.251b 0.024*
After volume/Before volume 1.153b 0.249ns
After class D/Before class D 0.676a 0.499ns
After class C/Before class C 0.676a 0.499ns
After class B/Before class B 1.014b 0.310ns
After class A/Before class A 1.48b 0.138ns
After sperm motility total/Before sperm motility total 0.845b 0.398ns
After sperm count/Before sperm count 1.521b 0.128ns
After WBC/Before WBC 1.461a 0.144ns

Table 1: Comparison of semen parameters before and after the antibiotic therapy.

Sperm parameters Sperm parameters Before treatment SEM After treatment SEM P-Value
WBCs (million/ml) WBCs 0.41 0.195 0.09 0.055 0.0144
Sperm count (million/ml) CS 57.11 15.04 68.31 17 0.128
Total sperm motility class A+B+C (%) TSM 39.67 10.53 47.09 8.064 0.398
Progressive motility class A (%) PMA 2 0.813 7.29 3.655 0.138
Progressive motility class B (%) PMB 20.89 5.556 22.97 6.534 0.31
Nonprogressive motility class C (%) NPM 16.79 5.163 15.51 3.58 0.499
Immotile class D (%) ID 60.33 10.53 54.23 8.567 0.499
Semen volume (ml) SV 3.13 0.796 3.6 0.765 0.249
Normal sperm morphology (%) NSM 3.86 1.243 5.14 1.317 0.024
Semen pH SP 7.83 0.028 7.77 0.041 0.157
ROS  base (RLU/sec/× 106 sperm) ROSB 62.52 6.834 30.19 1.419 0.043
ROS WBCs (RLU/sec/× 106 sperm) ROSW 82.44 10.842 33.84 1.809 0.043
ROS total   (RLU/sec/× 106 sperm) ROST 133.02 31.514 44.17 5.326 0.043

Table 2: Comparison of semen parameters in infected patients of the study group (infertile men) before and after the antibiotic therapy.

infectious-diseases-parameters

Figure 1: Linear chart for comparison of semen parameters in infected infertile men, before and after the antibiotic therapy. Abbrevations: SV: Semen Volume (Ml); SC: Sperm Count (Million Per Ml); SC: Sperm Count (Million); TSM: Total Sperm Motility Class A+B+C (%); PMA: Progressive Motility Class A (%); PMB: Progressive Motility Class B (%); TPM: Total Progressive Motility Class A+B (%); ID: Immotile Class D (%) ; NPM; Nonprogressive Motility Class C (%); NSM: Normal Sperm Morphology (%);SP: Semen Ph; WBCs: White Blood Cells (Million Per Ml ); ROS B: Reactive Oxygen Species Base(RLU/Sec/ × 106 Sperm); ROSW: Reactive Oxygen Species WBCs (RLU/Sec/ × 106 Sperm); ROST: Reactive Oxygen Species Total (RLU/Sec/ × 106 Sperm). Error Bars Are Standard Error of the Mean (SEM).

ROS level and semen WBC

Tables 1 and 2 compares the ROS before and after the antibiotic therapy and (Figure 1) compares the ROS level in infected infertile men before and after the antibiotic therapy. The ROS level was significantly was decreased after treatment (P-value=0.043). The level of ROS WBCs was significantly was decreased (P-value=0.043). The total ROS was significantly was decreased after treatment (P-value=0.043) (Table 3). No significant correlation was found between Chlamydia infection and White Blood Cell Count (WBC).

Mill/ml Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Sample 7
WBC before treatment 0 1 0 0 1 0.9 0
WBC after treatment 0 0 0.3 0 0.3 0 0

Table 3: Count of WBC in the samples before and after treatment. In overall comparison, there Leukocyte reduction after treatment, the difference was not significant.

First and second PCR photo from gel agarose using primers F1-R1 and F2-R2

The results (Figures 2 and 3) Showed that ROS base and ROS, WBC and total ROS and Normal morphology were significantly improved after treatment (P<0.05). Variables such as; count of leukocytes, Sperm count, motility (total), Class A (rapid progressive), class D (immotile), volume of Semen, and Semen pH showed improvement but this improvement was not statistically significant (P>0.05.). In variables such as motility of the Class B (progressive) and class C (nonprogressive) no differences were observed.

infectious-diseases-samples

Figure 2: The second PCR 1.0 % gel agarose using primers F2-R2 (317 bands bp). Note: First row from left to right as follows: Chlamydia trachomatis DNA Ladder 50bp- positive control (317 band bp)- positive samples (317 band bp) -12 sample negative - positive samples (317 band bp) -3 negative samples 2nd row from left to right as follows: DNA Ladder50bp - 9 negative samples.

infectious-diseases-agarose

Figure 3: The first PCR photo from 1.0 % gel agarose using primers F1-R1 (517 band bp). From left to right are as follows: DNA Ladder50bp - positive sample Negative sample (517 band bp) - 5 samples positive sample Negative (517 band bp) - 4 negative samples.

Discussion

The results showed that chlamydia infection and the rate of ROS and Sperm parameters were co-related in the infertile men (those tested PCR positive), because after medication and infection (negative PCR test after treatment) the rate of ROS was decreased and some Sperm parameters had been improved. Chlamydia is most likely a direct adhesion to the Sperm causing Infertility [13]. In 50%-80% of cases is asymptomatic infection [14]. Anyone with Chlamydia trachomatis infection should be followed up 3-12 month of treatment [15]. Chlamydia trachomatis causes common bacterial STD in the world and responsible for at least 50% of the causes of pelvic inflammatory disease and 87% of men and women infection. Chlamydia trachomatis is the most common pathogen identified in the No Gonococcal Urethritis (NGU) group, with up to 42% of NGU cases being caused by this bacterium [3]. There is an uncertainty about the role of C. trachomatis infection in Infertility and free Radicals of Oxygen (ROS) and even the type of sample (urine, Semen) as well as the type of diagnostic method. It was reported that increasing the count of leukocytes in Semen was correlated with poor Semen quality [16]. In men with chlamydial IgA positive, high percentage of dead Sperm and seminal fluid was observed in the prevalence of leukocytes [17]. In our study, although there was a relationship between the counts of leukocytes with chlamydial infection, however, this relationship was not statistically proven. Although the method of NAAT for detection of genital C.trachomatis in women’s and men’s have been reported but the PCR test were more sensitive, which could be used as a confirmatory test for C. trachomatis infection [18]. Combination of different methods screening for C. trachomatis should be used in research because there is no approved method for Chlamydia in Semen. PCR and ligase chain reaction are more sensitive [19]. The diagnostic method used in our study was close to the studies conducted by Hosseinzadeh, Embrey and Templeton, in which, the first was by Elisa and confirmed by Nested PCR. In the study of Hosseinzadeh two primer pairs were used for the diagnosis of C. trachomatis and our study was consistent with these studies [20]. Our results were also consistent with the study conducted by Elisa and PCR [21]. C. trachomatis in prostatitis patients affected parameters such as Sperm concentration, percentage of Sperm motility [22]. Men with CT infection showed poor Semen quality [13,20].

The association between CT infection and Semen weakening was observed [23-27]. Some studies suggested that some bacterial species had negative effects on Sperm parameters including motility and morphology [2,22,26,28,29]. Those results were consistent with the results of us in the current study. Two studies by Metric showed that CT infection altered Sperm parameters [30].

In our study, ROS level and normal morphology were significantly improved after treatment. Parameters such as; was decreased leukocyte count, was increased Sperm count, was increased total motility, was increased class A (rapid progressive), was decreased class D (immotile), was increased Semen volume and was increased acidification of Semen, however, those parameters were not proven statistically. According to Gouda the mean of Semen volume, Sperm concentration, viability, motility, morphology, and the WBC count were not affected by chlamydial infection [31]. High leukocyte counts in Semen may be an inflammatory marker in the male reproductive system [32]. The Centers for Disease Control and Prevention recommends azithromycin or doxycycline for the treatment of C.trachomatis infection in which the latter was used, in this study.

An abnormal increase in Semen leukocytes due to was increased ROS levels could lead to Sperm damage [33,34]. In our study, pretreatment ROS levels were high compared with post-treatment, and ROS was decreased significantly after drug administration and infection removal.

Patient enrolment and ethical statement

The ethical approval for patient enrolment in this study was obtained from the Ethics Committee of Royan institute (IR.ACECR. ROYAN.REC.1394.84). The patients in this study were selected from men consecutively admitted to the Royan Institute in Tehran, Iran. All participants as well as their sexual partners provided written consent letter.

Inclusion-exclusion criteria, semen collection and analysis

All the patients were clinically examined and asked for past medical, sexual, and social histories. The study population consisted of men who referred to Royan Institute with Chlamydia trachomatis infection. Eight hundred and forty-eight patients with normal and abnormal Sperm parameters (low Sperm count, pyoSpermia, low Sperm progressive motility, low normal morphology) were included.

Patients with symptoms such as genitourinary tract infections, reproductive system abnormalities, varicocele, testicular tumors, systemic diseases, non-compliance with Spermogram test conditions, and those with a history of antibiotic use in the previous week were not included in our study.

This study was a cross-sectional study, Semen samples were collected into sterile sample cups through self-administered masturbation, after 3-7 days of sexual abstinence. Samples were put in the incubator directly for liquefaction and then manually analyzed by the same person for volume, viscosity, pH, presence of White Blood Cells (WBCs), Sperm concentration (count per ml and total count), motility (classes A, B, A+B, C, and total), and normal morphology, as indicated by the latest WHO manual for Semen analysis (Organization, 2010). Semen analysis was confirmed using a light microscope equipped with a Computer-Aided Semen Analysis (CASA; Test Sperm2.1, Video test, St. Petersburg, Russia) system. The presence of leukocytes in seminal fluid was detected by peroxidase test. Sperm morphology was detected by staining papanicolaou procedure.

In the first appointment, Semen samples from infertile men were collected in sterile containers and each sample was divided into two parts; the first part for Semen analysis and the next part for Sperm parameters. To evaluate the first part, Sperms were kept into sterile vials in order to perform the Elisa test and PCR at -70°C until testing was contained. After the centrifugation, plasma samples were analyzed by Elisa test samples and sediment samples were used for DNA extraction. After the infection confirmation by PCR, patients were asked to visit the second visit interval of 3 days from the last ejaculation for Sperm analysis and ROS tests. Antibiotics (every 12 h for two weeks) were also prescribed for them. After the completion of antibiotic usage, if the patients were not resolved from the infection, the treatment continued taking the same antibiotic with the same dose for another week. In order to assess the effect of the empirical antibiotic treatment on Semen parameters ROS levels, as well as clearance from infection, a subsequent Semen sample was taken 30 days after completion of the antibiotic therapy, by considering the 3-7 days of sexual abstinence.

Elisa test

To detect specific IgA, antibodies to C. trachomatis by Elisa (Vircell kit IgA: A 1017) a serological assay kit was used and negative controls on each slide were included from the kit. Sample OD was higher (Cut off control: <0.4, 1.5>) in patients who were suspected of being infected or near Cut of (0.4). The DNA extraction and PCR were performed to confirm the presence of infection by Nested PCR.

Nested PCR

Nested plasmid PCR for C. trachomatis was conducted according to a previously published method on all extracted DNA from Semen. Two pairs of primers were used to detect C. trachomatis as previously described. Products were analyzed by gel electrophoresis in 1.0% agarose with sybr green staining. DNA of C. trachomatis was extracted from Semen samples using QIAamp mini kit: 51306 according to the manufacturer’s instructions. A negative Control of Extraction was used in the extraction procedure and Internal Control, which served as extraction and amplification control, was directly added to the sample/ lysis mixture during the DNA extraction. Absorbance readings and Genomic detection of Chlamydia trachomatis in Semen samples were conducted by spectrophotometer and Nested PCR, respectively. In brief, dNTP (5 mm) takara company, MgCl2 (25 mm) takara company, PCR Buffer (10X) takara company, Taq DNA Polymerase innotrain company, F1/R1،F2/R2 primers (Farayand Danesh co) were used in this study. The contents of Master Mix (25 μl); PCR buffer (10X) 2.5 μl, Mgcl2 (25 mm) 1.5 μl, dNTPs Mix (10 mm) 0.7 μl, Forward primer (10 pmol/μl) 1.6 μl, Reverse primer (10 pmol/μl) 1.6 μl, Smar Taq DNA Polymerase (50 u/μl) 0.5 μl, dd H2O 11.6 μl, DNA template 5 μl. PCR Amplification Protocol: Initiation Denaturation for 94° C for 5 min 1 Cycles, Denaturation 94°C for 30 sec 40 Cycles, Annealing 59°C for 30 sec 40 Cycles, Extension 72°C for 30 sec 40 Cycles, Final Extension for 72°C for 7 min 1 Cycles. Primers: F1 (5’-GGACAAATCGTATCTCGG-3’) R 1 ( 5 ’ - G A A A C C A A C T C T A C G C T G - 3 ’ ) F 2 ( 5 ’ - A T C C A T T G C G T A G A T C T C C G - 3 ’ ) R 2 (5’-GCCATGTCTATAGCTAAAGC-3’).

ROS measurement

Measurement of ROS in Semen specimens was performed according to the WHO laboratory manual for the examination and processing of human Semen (Organization, 2010). Spermatozoa were washed in Krebs–Ringer Medium (KRM) and adjusted to 10 × 106 Spermatozoa per ml. Chemiluminescent probes, including luminal, Formyl-Methionyl-Leucyl-Phenylalanine (FMLP), and Phorbol 12 Myristate 13-Acetate (PMA) were utilized to detect extracellular, WBCs and Spermatozoa generated ROS, respectively. Chemiluminescent signals were monitored using a luminometer (Synergy TM H4 Hybrid Multi-Mode Microplate Reader, BioTek, USA), and final ROS level was calculated as relative light units Sperm. (RLU/sec/× 106 Sperm).

Antibiotic treatment and patients’ follow-up

Patients and their sexual partner detected positive for C. trachomatis, were treated with doxycycline (Razak Laboratories, Tehran, Iran), 100 mg orally twice daily for 7 days [35,36]. To assess the effect of the empirical antibiotic treatment on Semen parameters, ROS levels, as well as clearance from infection, a subsequent Semen sample was taken 30 days after completion of the antibiotic therapy [37], also considering the 3-7 days of sexual abstinence [38]. Semen analysis, PCR, ROS assessment, as well as calculation of ROS ratio, were performed on these specimens, as already described for the first samples.

Statistical method

Non-parametric test Wilcoxon (non-parametric statistical test to compare two dependent groups) was used to analyze the data [39]. The appropriate test plans before and after (a sample on two occasions), non-parametric Wilcoxon test considers the size of the difference between ranking. The P-value<0.05 was considered as statistically significant [40].

Conclusion

In conclusion, medication with antibiotics showed to be effective in infected Patients Whose Nested PCR was positive. The quality of natural Sperm morphology and some other Semen parameters improved. ROS level was also was decreased. The results of the present study indicated that asymptomatic infections caused by CT were associated with male Infertility and high WBC and abnormal Sperm parameters do not indicate infection with this bacterium. Our findings indicate the importance of screening programs for asymptomatic infections due to this bacterium and its treatment. Our findings will also be helpful for infected patients who have abnormal Semen parameters to maintain fertility and reproductive health.

Acknowledgements

This research has been supported by supported by Royan institute for Reproductive Biomedicine.

Disclosure statement

The other authors have no competing interests to disclose.

Ethics Approval

The ethical approval for patient enrolment in this study was obtained from the Ethics Committee of Royan institute (IR.ACECR. ROYAN.REC.1394.84).

Funding

This study was funded by Royan institute for Reproductive Biomedicine.

Author contribution

Analyzed the data, evaluated the results, and wrote the paper: RA

References

  1. Mishori R, McClaskey EL, WinklerPrins V (2012) Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician 86:1127-1132.

Citation: Azmakan R, Yazdi RS, Farahi F, Esmaeili V, Bidoki SK, et al. (2020) The Effect of Post Chlamydia Trachomatis Infection Treatment on Reactive Oxygen Species and Sperm Parameters of Infertile Men. J Infect Dis Ther 8:435. DOI: 10.4172/2332-0877.1000435

Copyright: © 2020 Azmakan R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top